466 related articles for article (PubMed ID: 19924243)
1. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
Kam YW; Okumura Y; Kido H; Ng LF; Bruzzone R; Altmeyer R
PLoS One; 2009 Nov; 4(11):e7870. PubMed ID: 19924243
[TBL] [Abstract][Full Text] [Related]
2. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
Bertram S; Glowacka I; Müller MA; Lavender H; Gnirss K; Nehlmeier I; Niemeyer D; He Y; Simmons G; Drosten C; Soilleux EJ; Jahn O; Steffen I; Pöhlmann S
J Virol; 2011 Dec; 85(24):13363-72. PubMed ID: 21994442
[TBL] [Abstract][Full Text] [Related]
3. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.
Glowacka I; Bertram S; Herzog P; Pfefferle S; Steffen I; Muench MO; Simmons G; Hofmann H; Kuri T; Weber F; Eichler J; Drosten C; Pöhlmann S
J Virol; 2010 Jan; 84(2):1198-205. PubMed ID: 19864379
[TBL] [Abstract][Full Text] [Related]
4. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
[TBL] [Abstract][Full Text] [Related]
6. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.
Han DP; Penn-Nicholson A; Cho MW
Virology; 2006 Jun; 350(1):15-25. PubMed ID: 16510163
[TBL] [Abstract][Full Text] [Related]
7. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus.
Xu L; Zhang Y; Liu Y; Chen Z; Deng H; Ma Z; Wang H; Hu Z; Deng F
J Gen Virol; 2009 Nov; 90(Pt 11):2695-2703. PubMed ID: 19625462
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry.
Hou Y; Peng C; Yu M; Li Y; Han Z; Li F; Wang LF; Shi Z
Arch Virol; 2010 Oct; 155(10):1563-9. PubMed ID: 20567988
[TBL] [Abstract][Full Text] [Related]
10. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2.
Glende J; Schwegmann-Wessels C; Al-Falah M; Pfefferle S; Qu X; Deng H; Drosten C; Naim HY; Herrler G
Virology; 2008 Nov; 381(2):215-21. PubMed ID: 18814896
[TBL] [Abstract][Full Text] [Related]
11. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.
Wang H; Yang P; Liu K; Guo F; Zhang Y; Zhang G; Jiang C
Cell Res; 2008 Feb; 18(2):290-301. PubMed ID: 18227861
[TBL] [Abstract][Full Text] [Related]
12. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.
Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C
Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741
[TBL] [Abstract][Full Text] [Related]
13. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.
Ho TY; Wu SL; Chen JC; Li CC; Hsiang CY
Antiviral Res; 2007 May; 74(2):92-101. PubMed ID: 16730806
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Li W; Moore MJ; Vasilieva N; Sui J; Wong SK; Berne MA; Somasundaran M; Sullivan JL; Luzuriaga K; Greenough TC; Choe H; Farzan M
Nature; 2003 Nov; 426(6965):450-4. PubMed ID: 14647384
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
16. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry.
Haga S; Yamamoto N; Nakai-Murakami C; Osawa Y; Tokunaga K; Sata T; Yamamoto N; Sasazuki T; Ishizaka Y
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7809-14. PubMed ID: 18490652
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new region of SARS-CoV S protein critical for viral entry.
Guo Y; Tisoncik J; McReynolds S; Farzan M; Prabhakar BS; Gallagher T; Rong L; Caffrey M
J Mol Biol; 2009 Dec; 394(4):600-5. PubMed ID: 19853613
[TBL] [Abstract][Full Text] [Related]
18. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
Belouzard S; Chu VC; Whittaker GR
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428
[TBL] [Abstract][Full Text] [Related]
19. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2.
Li W; Sui J; Huang IC; Kuhn JH; Radoshitzky SR; Marasco WA; Choe H; Farzan M
Virology; 2007 Oct; 367(2):367-74. PubMed ID: 17631932
[TBL] [Abstract][Full Text] [Related]
20. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
